What is the recommended dose of Buscopan (Hyoscine butylbromide) for treating abdominal cramps and spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing of Buscopan (Hyoscine butylbromide) for Abdominal Cramps and Spasms

For adults and children 12 years and older, the recommended dose of Buscopan (Hyoscine butylbromide) is 1-2 tablets (10-20 mg) every four hours as needed, not exceeding 12 tablets (120 mg) in 24 hours. 1

Dosage Guidelines

  • For adults and pediatric patients 12 years and older: 1-2 tablets (10-20 mg) every four hours as needed, with a maximum of 12 tablets in 24 hours 1
  • For pediatric patients 2 to under 12 years of age: ½ to 1 tablet (5-10 mg) every four hours as needed, with a maximum of 6 tablets in 24 hours 1
  • Tablets may be taken sublingually, orally, or chewed 1

Mechanism of Action

  • Buscopan (Hyoscine butylbromide) is an antispasmodic drug with high affinity for muscarinic receptors located on smooth muscle cells of the gastrointestinal tract 2
  • Its anticholinergic action exerts a smooth-muscle relaxing/spasmolytic effect, which is the basis for its use in treating abdominal pain secondary to cramping 2
  • Buscopan also binds to nicotinic receptors, inducing a ganglion-blocking effect that may contribute to its spasmolytic activity 3

Pharmacokinetics

  • Hyoscine butylbromide has low systemic availability after oral administration, with plasma concentrations generally below the limit of quantitation 2
  • The bioavailability is generally <1% as estimated from renal excretion 2
  • Despite low systemic availability, its high tissue affinity for muscarinic receptors allows it to remain available at the site of action in the intestine and exert a local spasmolytic effect 2

Clinical Efficacy

  • Buscopan has been shown to be effective in treating abdominal pain caused by cramping in multiple placebo-controlled studies 2
  • It produces a significant reduction in pain scores among patients with irritable bowel syndrome with predominant diarrhea (IBS-D) 4
  • Research suggests that the clinical benefits of Buscopan may relate more to effects on visceral sensation than motility 4
  • In a randomized controlled trial, parenteral Buscopan 20 mg was not inferior to anisodamine in pain relief for patients with acute gastric or intestinal spasm-like pain 5

Safety Profile

  • Buscopan is generally well tolerated due to its minimal absorption and inability to penetrate the blood-brain barrier 2
  • Common side effects include dry mouth, thirst, and visual disturbances 5, 6
  • No significant increases in the incidence of anticholinergic-related adverse effects have been observed in clinical trials 2

Clinical Considerations

  • Antispasmodics like Buscopan are among the most frequently used over-the-counter treatments for irritable bowel syndrome (IBS) 6
  • The British Society of Gastroenterology guidelines note that certain antispasmodics may be effective for global symptoms and abdominal pain in IBS, though the quality of evidence is very low 6
  • When using antispasmodics for IBS, patients should be warned about potential side effects such as dry mouth, visual disturbance, and dizziness 6

Special Populations

  • For parenteral administration in acute settings, a single dose of 20 mg has been studied with the option for a second dose when needed 5
  • Careful dose titration may help avoid common side effects such as constipation, nausea, and dry mouth 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.